173 related articles for article (PubMed ID: 12410848)
41. AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions.
Sanajou D; Ghorbani Haghjo A; Argani H; Aslani S
Eur J Pharmacol; 2018 Aug; 833():158-164. PubMed ID: 29883668
[TBL] [Abstract][Full Text] [Related]
42. Terpene glycoside component from Moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses.
Chen J; Hou XF; Wang G; Zhong QX; Liu Y; Qiu HH; Yang N; Gu JF; Wang CF; Zhang L; Song J; Huang LQ; Jia XB; Zhang MH; Feng L
J Ethnopharmacol; 2016 Dec; 193():433-444. PubMed ID: 27664441
[TBL] [Abstract][Full Text] [Related]
43. Physiologic actions and molecular expression of the renin-angiotensin system in the diabetic rat.
Anderson S
Miner Electrolyte Metab; 1998; 24(6):406-11. PubMed ID: 9930380
[TBL] [Abstract][Full Text] [Related]
44. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H
Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678
[TBL] [Abstract][Full Text] [Related]
45. Molecular mechanisms of diabetic nephropathy and its therapeutic intervention.
Yamagishi S; Fukami K; Ueda S; Okuda S
Curr Drug Targets; 2007 Aug; 8(8):952-9. PubMed ID: 17691932
[TBL] [Abstract][Full Text] [Related]
46. Beneficial effects of β-conglycinin on renal function and nephrin expression in early streptozotocin-induced diabetic nephropathy rats.
Yang HY; Wu LY; Yeh WJ; Chen JR
Br J Nutr; 2014 Jan; 111(1):78-85. PubMed ID: 23803175
[TBL] [Abstract][Full Text] [Related]
47. Genetic markers of increased susceptibility to diabetic nephropathy.
Doria A
Horm Res; 1998; 50 Suppl 1():6-11. PubMed ID: 9676990
[TBL] [Abstract][Full Text] [Related]
48. Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.
Jourdan T; Szanda G; Rosenberg AZ; Tam J; Earley BJ; Godlewski G; Cinar R; Liu Z; Liu J; Ju C; Pacher P; Kunos G
Proc Natl Acad Sci U S A; 2014 Dec; 111(50):E5420-8. PubMed ID: 25422468
[TBL] [Abstract][Full Text] [Related]
49. Vitamin D protection from rat diabetic nephropathy is partly mediated through Klotho expression and renin-angiotensin inhibition.
Eltablawy N; Ashour H; Rashed LA; Hamza WM
Arch Physiol Biochem; 2018 Dec; 124(5):461-467. PubMed ID: 29308676
[TBL] [Abstract][Full Text] [Related]
50. Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.
Lakshmanan AP; Watanabe K; Thandavarayan RA; Sari FR; Harima M; Giridharan VV; Soetikno V; Kodama M; Aizawa Y
Free Radic Res; 2011 May; 45(5):575-84. PubMed ID: 21381899
[TBL] [Abstract][Full Text] [Related]
51. Advanced glycation end products.
Thomas MC
Contrib Nephrol; 2011; 170():66-74. PubMed ID: 21659759
[TBL] [Abstract][Full Text] [Related]
52. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
53. The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets.
Steckelings UM; Rompe F; Kaschina E; Unger T
Fundam Clin Pharmacol; 2009 Dec; 23(6):693-703. PubMed ID: 19817870
[TBL] [Abstract][Full Text] [Related]
54. The locally activated renin-angiotensin system is involved in albumin permeability in glomerular endothelial cells under high glucose conditions.
Paeng J; Park J; Um JE; Nam BY; Kang HY; Kim S; Oh HJ; Park JT; Han SH; Ryu DR; Yoo TH; Kang SW
Nephrol Dial Transplant; 2017 Jan; 32(1):61-72. PubMed ID: 27358275
[TBL] [Abstract][Full Text] [Related]
55. Angiotensin blockade in type 2 diabetic renal disease.
Ruilope LM; Luño J
Kidney Int Suppl; 2002 Dec; (82):S61-3. PubMed ID: 12410857
[TBL] [Abstract][Full Text] [Related]
56. Intestinal dysbiosis activates renal renin-angiotensin system contributing to incipient diabetic nephropathy.
Lu CC; Ma KL; Ruan XZ; Liu BC
Int J Med Sci; 2018; 15(8):816-822. PubMed ID: 30008592
[TBL] [Abstract][Full Text] [Related]
57. Review: Endothelial-myofibroblast transition, a new player in diabetic renal fibrosis.
Li J; Bertram JF
Nephrology (Carlton); 2010 Aug; 15(5):507-12. PubMed ID: 20649869
[TBL] [Abstract][Full Text] [Related]
58. [Effects of Shenkangwan on renal expressions of angiotensin II and its type I receptor in rats with early diabetic nephropathy].
Long HB; Niu HX; Li XY; Xu ZZ; Zhang H; Zhong J; Wei LB
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):805-9. PubMed ID: 20423855
[TBL] [Abstract][Full Text] [Related]
59. Role of O-linked N-acetylglucosamine modification in diabetic nephropathy.
Gellai R; Hodrea J; Lenart L; Hosszu A; Koszegi S; Balogh D; Ver A; Banki NF; Fulop N; Molnar A; Wagner L; Vannay A; Szabo AJ; Fekete A
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1172-F1181. PubMed ID: 27029430
[TBL] [Abstract][Full Text] [Related]
60. Pathogenesis of diabetic nephropathy.
Raptis AE; Viberti G
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S424-37. PubMed ID: 11460589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
